Renaud Ronald C Jr - Net Worth and Insider Trading
Renaud Ronald C Jr Net Worth
The estimated net worth of Renaud Ronald C Jr is at least $4 Million dollars as of 2024-11-05. Renaud Ronald C Jr is the President & CEO of Cerevel Therapeutics Holdings Inc and owns about 83,857 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $4 Million. Renaud Ronald C Jr is also the CEO of Translate Bio Inc and owns about 0 shares of Translate Bio Inc (TBIO) stock worth over $0. Details can be seen in Renaud Ronald C Jr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Renaud Ronald C Jr has not made any transactions after 2023-08-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Renaud Ronald C Jr
Renaud Ronald C Jr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Renaud Ronald C Jr owns 8 companies in total, including Atara Biotherapeutics Inc (ATRA) , Translate Bio Inc (TBIO) , and Chimerix Inc (CMRX) among others .
Click here to see the complete history of Renaud Ronald C Jr’s form 4 insider trades.
Insider Ownership Summary of Renaud Ronald C Jr
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATRA | Atara Biotherapeutics Inc | 2021-06-08 | director |
| TBIO | Translate Bio Inc | 2021-09-14 | director & Chief Executive Officer & other: President |
| CMRX | Chimerix Inc | 2014-12-17 | director |
 | | 2014-09-12 | director |
| | 2017-01-03 | director |
| | 2007-02-14 | Chief Financial Officer |
| | 2021-03-25 | director |
| | 2023-08-03 | director & President & CEO |
Renaud Ronald C Jr Latest Holdings Summary
Renaud Ronald C Jr currently owns a total of 2 stocks. Among these stocks, Renaud Ronald C Jr owns 83,857 shares of Cerevel Therapeutics Holdings Inc (CERE) as of August 3, 2023, with a value of $4 Million and a weighting of 100%. Renaud Ronald C Jr also owns 0 shares of Translate Bio Inc (TBIO) as of September 14, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of Renaud Ronald C Jr
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings Inc | 2023-08-03 | 83,857 | 44.96 | 3,770,211 |
| TBIO | Translate Bio Inc | 2021-09-14 | 0 | 37.36 | 0 |
Holding Weightings of Renaud Ronald C Jr
Renaud Ronald C Jr Form 4 Trading Tracker
According to the SEC Form 4 filings, Renaud Ronald C Jr has made a total of 1 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the acquisition of 83,857 shares on August 3, 2023, which cost Renaud Ronald C Jr around $2 Million.
According to the SEC Form 4 filings, Renaud Ronald C Jr has made a total of 1 transactions in Translate Bio Inc (TBIO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Translate Bio Inc is the sale of 954,053 shares on September 14, 2021, which brought Renaud Ronald C Jr around $36 Million.
Insider Trading History of Renaud Ronald C Jr
- 1
Renaud Ronald C Jr Trading Performance
GuruFocus tracks the stock performance after each of Renaud Ronald C Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Renaud Ronald C Jr is 10.94%. GuruFocus also compares Renaud Ronald C Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Renaud Ronald C Jr within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Renaud Ronald C Jr's insider trading performs compared to the benchmark.
Performance of Renaud Ronald C Jr
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.42 | | | | | |
| Relative Return to S&P 500(%) | -0.73 | | | | | |
Renaud Ronald C Jr Ownership Network
Ownership Network List of Renaud Ronald C Jr
Ownership Network Relation of Renaud Ronald C Jr
Renaud Ronald C Jr Owned Company Details
What does Atara Biotherapeutics Inc do?
Who are the key executives at Atara Biotherapeutics Inc?
Renaud Ronald C Jr is the director of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , SVP & GC & Secretary Amar Murugan , and director & President and CEO Pascal Touchon .
Atara Biotherapeutics Inc (ATRA) Insider Trades Summary
Over the past 18 months, Renaud Ronald C Jr made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 204,620 shares made by Pascal Touchon , a net sale of 68,971 shares made by Amar Murugan , and a net sale of 64,459 shares made by Eric J Hyllengren .
In summary, during the past 3 months, insiders sold 8,050 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 8,050 shares. During the past 18 months, 27,448 shares of Atara Biotherapeutics Inc (ATRA) were sold and 32,673 shares were bought by its insiders, resulting in a net purchase of 5,225 shares.
Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atara Biotherapeutics Inc Insider Transactions
Renaud Ronald C Jr Mailing Address
Above is the net worth, insider trading, and ownership report for Renaud Ronald C Jr. You might contact Renaud Ronald C Jr via mailing address: C/o Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge Ma 02109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
